Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin®) in patients with advanced non-squamous non-small cell lung cancer

被引：0
作者：
Cheryl S. W. Li
Kevin Sweeney
Carol Cronenberger
机构：
[1] Pfizer Global Product Development,Clinical Pharmacology/Pharmacometrics
[2] Pfizer Inc.,Clinical Pharmacology/Pharmacometrics
[3] Pfizer Global Product Development,Clinical Pharmacology/Pharmacometrics
[4] Pfizer Inc.,undefined
[5] Pfizer Global Product Development,undefined
[6] Pfizer Inc.,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 85卷
关键词：
Bevacizumab; Biosimilar; Non-small cell lung cancer; PF-06439535; Population pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：487 / 499
页数：12
相关论文
共 62 条
  • [51] Millan S(undefined)undefined undefined undefined undefined-undefined
  • [52] Yan X(undefined)undefined undefined undefined undefined-undefined
  • [53] Lowe PJ(undefined)undefined undefined undefined undefined-undefined
  • [54] Fink M(undefined)undefined undefined undefined undefined-undefined
  • [55] Berghout A(undefined)undefined undefined undefined undefined-undefined
  • [56] Balser S(undefined)undefined undefined undefined undefined-undefined
  • [57] Krzyzanski W(undefined)undefined undefined undefined undefined-undefined
  • [58] Reijers JA(undefined)undefined undefined undefined undefined-undefined
  • [59] van Donge T(undefined)undefined undefined undefined undefined-undefined
  • [60] Schepers FM(undefined)undefined undefined undefined undefined-undefined
1234567